9/20/17 19:14 | 9/20/17 | ANTH | Anthera Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | CA | DO | P,CEO | P | 11 | 1.32 | 0 | 9 | 76 | 20 | D | | | | | | | | | | | | | | |
9/7/17 18:56 | 9/7/17 | ANTH | Anthera Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | CA | DO | P,CEO | P.a | 15 | 1.43 | 0 | 10 | 999% | 11 | D | | | | | | | | | | | | | | |
9/7/17 14:43 | 9/7/17 | ANTH | Anthera Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | CA | DO | P,CEO | M | 15 | 1.43 | 0 | 10 | 145 | 18 | D | | | | | | | | | | | | | | |
9/10/15 21:14 | 9/8/15 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | MA | O | COO | M.d | 145 | 14.45 | 33 | 10 | | 0 | D | -9 | -41 | -74 | -78 | -80 | -78 | -78 | -78 | 4 | 17 | 10 | 24 | -44 | -47 |
9/10/15 21:14 | 9/8/15 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | MA | O | COO | S.d | -441 | 44.08 | 33 | -10 | -97 | 0 | D | -9 | -41 | -74 | -78 | -80 | -78 | -78 | -78 | 4 | 17 | 10 | 24 | -44 | -47 |
8/7/15 18:48 | 8/5/15 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | MA | O | COO | M.d | 145 | 14.45 | 20 | 10 | | 0 | D | 415 | 289 | 22 | 8 | -11 | -19 | -13 | -12 | 5 | 1 | 1 | -77 | -91 | -93 |
8/7/15 18:48 | 8/5/15 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | MA | O | COO | S.d | -463 | 46.31 | 20 | -10 | -97 | 0 | D | 415 | 289 | 22 | 8 | -11 | -19 | -13 | -12 | 5 | 1 | 1 | -77 | -91 | -93 |
7/8/15 17:37 | 7/6/15 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | MA | O | COO | M.d | 145 | 14.45 | 23 | 10 | | 0 | D | 554 | 317 | 22 | 33 | 13 | 13 | 3 | 1 | 0 | 5 | 0 | -79 | -79 | -88 |
7/8/15 17:37 | 7/6/15 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | MA | O | COO | S.d | -479 | 47.91 | 23 | -10 | -97 | 0 | D | 554 | 317 | 22 | 33 | 13 | 13 | 3 | 1 | 0 | 5 | 0 | -79 | -79 | -88 |
6/16/15 19:19 | 6/15/15 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | MA | O | COO | M.d | 145 | 14.45 | 20 | 10 | | 0 | D | 443 | 275 | 34 | 8 | 15 | 0 | 3 | 1 | 2 | 8 | 18 | -77 | -77 | -91 |
6/16/15 19:19 | 6/15/15 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | MA | O | COO | S.d | -415 | 41.51 | 20 | -10 | -97 | 0 | D | 443 | 275 | 34 | 8 | 15 | 0 | 3 | 1 | 2 | 8 | 18 | -77 | -77 | -91 |
6/10/15 20:38 | 6/8/15 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | MA | O | COO | M.d | 325 | 14.45 | 20 | 22 | | 0 | D | 452 | 294 | 52 | 19 | 11 | 4 | -1 | 2 | 1 | 1 | 10 | 6 | -76 | -90 |
6/10/15 20:38 | 6/8/15 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | MA | O | COO | S.d | -973 | 43.26 | 20 | -22 | -98 | 0 | D | 452 | 294 | 52 | 19 | 11 | 4 | -1 | 2 | 1 | 1 | 10 | 6 | -76 | -90 |
5/19/15 16:43 | 5/15/15 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | MA | O | COO | M.d | 434 | 14.45 | 18 | 30 | | 0 | D | 407 | 364 | 77 | 16 | 14 | 8 | 6 | 4 | 12 | 5 | 8 | 9 | -72 | -90 |
5/19/15 16:43 | 5/15/15 | TTPH | Tetraphase Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | MA | O | COO | S.d | -1,189 | 39.63 | 18 | -30 | -99 | 0 | D | 407 | 364 | 77 | 16 | 14 | 8 | 6 | 4 | 12 | 5 | 8 | 9 | -72 | -90 |
8/24/11 14:39 | 8/22/11 | TSRX | Trius Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Thompson John Craig | CA | O | Chief Co | P | 1 | 6.48 | 1 | 0 | New | 0 | D | | 59 | 3 | -19 | -17 | -24 | -3 | 3 | 2 | 4 | -3 | 14 | -19 | |